# GLP-1/GIP dual agonist tirzepatide in obstructive sleep apnea syndrome: mechanisms, evidence, and clinical perspectives.

> PubMed lists PMID 42136855 in Frontiers in medicine as Journal Article, Review, with publication-date metadata of 2026-04-29 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42136855-tirzepatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-05-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42136855-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42136855-tirzepatide-v1.json
- Content SHA-256: `045b710ce051c46ed2bc886df776f0a984136998ba83da5adad251a814ff5b20`

## Claims and source pins

### Headline

GLP-1/GIP dual agonist tirzepatide in obstructive sleep apnea syndrome: mechanisms, evidence, and clinical perspectives. ([`pubmed-observation-pmid-42136855-2026-05-15-8c651c83f6d4`](#source-pubmed-observation-pmid-42136855-2026-05-15-8c651c83f6d4))

### Summary

PubMed lists PMID 42136855 in Frontiers in medicine as Journal Article, Review, with publication-date metadata of 2026-04-29 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42136855-2026-05-15-8c651c83f6d4`](#source-pubmed-observation-pmid-42136855-2026-05-15-8c651c83f6d4))

### Paragraph 1

PubMed lists PMID 42136855 in Frontiers in medicine as Journal Article, Review, with publication-date metadata of 2026-04-29 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42136855-2026-05-15-8c651c83f6d4`](#source-pubmed-observation-pmid-42136855-2026-05-15-8c651c83f6d4))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42136855-2026-05-15-8c651c83f6d4`](#source-pubmed-observation-pmid-42136855-2026-05-15-8c651c83f6d4))

## Sources

<a id="source-pubmed-observation-pmid-42136855-2026-05-15-8c651c83f6d4"></a>
- **GLP-1/GIP dual agonist tirzepatide in obstructive sleep apnea syndrome: mechanisms, evidence, and clinical perspectives. · retained source version 1:2026-05-15:current:8c651c83f6d4aaa37355c4997fdb7cfe04b16f75cc31c285049aa197191d917a** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42136855/) (`pubmed-observation-pmid-42136855-2026-05-15-8c651c83f6d4`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "GLP-1/GIP dual agonist tirzepatide in obstructive sleep apnea syndrome: mechanisms, evidence, and clinical perspectives." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42136855-tirzepatide-v1.json SHA-256: 045b710ce051c46ed2bc886df776f0a984136998ba83da5adad251a814ff5b20.